Boston, Dec. 09, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Separation Systems for Commercial Biotechnology” is projected to grow from $32.5 billion in 2025 to $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.
The report provides a detailed analysis of the global market for bioseparation systems, focusing on revenue trends. It segments the market by product type, subtype, and region including North America, Europe, Asia-Pacific, and the Rest of the World. It highlights key market drivers and challenges, along with developments in environmental, social, and corporate governance (ESG), and emerging technologies that are shaping the industry.
It also examines the competitive landscape, offering insights into the market share and ranking of leading companies. A section on company profiles presents an overview of leading firms, including their financials, product portfolios, and recent strategic developments, helping stakeholders understand the market dynamics and competitive positioning.
The factors driving the market’s growth include:
Technological Advances in Bioseparation Systems and Investments in Biopharmaceuticals: Innovations in bioseparation technologies such as improved chromatography, membrane filtration, and centrifugation have improved the efficiency and precision of separating biological products. Simultaneously, rising investments in biopharmaceuticals driven by demand for biologics like vaccines and antibodies are fueling the need for advanced separation systems to support scalable and high-quality production.
Regulatory Compliance and Good Manufacturing Practices in the Biotechnology Industry: Strict regulatory frameworks and GMP standards require biotech companies to use validated and reliable separation systems to ensure product purity, safety, and consistency. Compliance with the FDA and EMA pushes manufacturers to adopt high performance bioseparation technologies that meet rigorous quality benchmarks.
Activity in Emerging Economies: Emerging economies such as India, China, and Brazil are experiencing rapid growth in biotechnology due to increased government support, healthcare expansion, and foreign investments. These regions are becoming more important in biopharma manufacturing and clinical research, driving demand for efficient and cost-effective bioseparation systems.
Potential Use of Bioseparation Systems in Clinical Diagnostics: Bioseparation technologies are increasingly used in clinical diagnostics to isolate biomarkers, proteins, and genetic material from biological samples. This application is vital for personalized medicine, early disease detection, and diagnostic accuracy making bioseparation systems essential tools in modern healthcare.
Request a sample copy of the global market for bioseparation systems report.
Report Synopsis
| Report Metric | Details |
| Base year considered | 2024 |
| Forecast period considered | 2025-2030 |
| Base year market size | $30.7 billion |
| Market size forecast | $45.1 billion |
| Growth rate | CAGR of 6.8% for the forecast period of 2025-2030 |
| Segments covered | Product, and Region |
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World |
| Countries covered | U.S., Canada, Mexico, Germany, France, the U.K., Italy, Spain, China, India, Japan, South Korea, Middle East and Africa, and South America |
| Market Drivers |
|
Interesting facts:
- The development and enhancement of ultra-high-performance liquid chromatography (UPLC) represents a major advance in chromatography technology. UPLC utilizes sub-2-micron particles and upgraded column technology to deliver faster, more efficient separations with higher resolution.
The report addresses the following questions:
- What are the projected market size and growth rate?
- The global market for bioseparation systems was valued at an estimated $30.6 billion in 2024 and is slated to reach $45.1 billion by the end of 2030.
- What factors are driving the growth of the market?
- Technological advances in bioseparation systems.
- Rising investments in biopharmaceuticals.
- Increasing regulatory compliance/GMP practices in the biotech industry.
- What market segments are covered in the report?
- The segments covered in the report include chromatography (gas chromatography liquid chromatography, thin layer chromatography, others), membrane filtration, flow cytometry, microarray, lab-on-a-chip, electrophoresis(gel, capillary), centrifugation (bench-top, floor model), and magnetic separation. It also covers macroeconomic factors, ESG initiatives and competitive analysis.
- Which product type segment will be dominant through 2030?
- The chromatography segment dominates the bioseparation systems and will continue to do so through 2030.
- Which region has the largest market share?
- North America holds the largest share of the market.
- What are the opportunities and challenges in the bioseparation systems market?
- The bioseparation systems market presents opportunities in emerging economies, including the potential use of bioseparation systems in clinical diagnostics. However, the market faces challenges such as the need for high capital expenditures, and variability in regulatory standards.
Market leaders include:
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- CYTIVA
- DANAHER CORP.
- EPPENDORF SE
- ILLUMINA INC.
- MERCK KGAA
- OXFORD GENE TECHNOLOGY IP LTD.
- REPLIGEN CORP.
- REVVITY
- SARTORIUS AG
- SHIMADZU CORP.
- THERMO FISHER SCIENTIFIC INC.
- TOSOH BIOSCIENCE GMBH
- WATERS CORP.
Related reports:
Global Biochip Markets: Microarrays and Lab-on-a-Chip: This report presents a detailed analysis of the global biochip market, examining key trends, challenges, and technological innovations. It segments the market by product type, technology, application, end-user industry, and region, covering North America, Europe, Asia-Pacific, and the Rest of the World. The study also explores ESG initiatives, patent activity, and emerging technologies. Additionally, it provides insights into the competitive landscape, including rankings and market shares of leading companies.
Global Markets for Media, Sera and Reagents in Biotechnology: This report provides a overview of the market for media, sera, and reagents in biotechnology, analyzing drivers, restraints, and opportunities. It covers emerging technologies, patent trends, ESG initiatives, investment outlooks, and industry deals. The market is segmented by product type: reagents, media, and sera, with further breakdowns based on composition, formulation, and source. It also categorizes the market by end users, including biopharmaceutical companies, academic institutions, and contract research organizations. Regional analysis spans North America, Europe, Asia Pacific, and the Rest of the World.
Purchase a copy of the report direct from BCC Research.
For further information on any of these reports or to make a purchase, contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
